This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
METHODS:The AHA, through its Epidemiology and Prevention Statistics Committee, continuously monitors and evaluates sources of data on heartdisease and stroke in the United States and globally to provide the most current information available in the annual Statistical Update with review of published literature through the year before writing.
METHODS:The AHA, through its Epidemiology and Prevention Statistics Committee, continuously monitors and evaluates sources of data on heartdisease and stroke in the United States and globally to provide the most current information available in the annual Statistical Update with review of published literature through the year before writing.
June 4, 2024 — The countdown has begun ahead of the American Society of Echocardiography 35th Annual ASE Scientific Sessions, June 14-26, at the Oregon Convention Center in Portland, OR. The Program Chair for ASE 2024 is Federico Asch, MD, FASE, MedStar Health and Georgetown University (Wash.,
milla1cf Tue, 06/11/2024 - 18:18 June 11, 2024 — Using an advanced artificial intelligence tool, researchers at the Icahn School of Medicine at Mount Sinai have identified rare coding variants in 17 genes that shed light on the molecular basis of coronary artery disease ( CAD ), the leading cause of morbidity and mortality worldwide.
milla1cf Mon, 01/29/2024 - 11:00 January 29, 2024 — The Society of Thoracic Surgeons has released late-breaking research scheduled for presentation at the 2024 Annual Meeting taking place January 27 - 29 in San Antonio.
A projected rise in heartdisease and stroke – along with several key risk factors, including high blood pressure and obesity – is likely to triple related costs to $1.8 christine.book Tue, 06/18/2024 - 11:22 June 18, 2024 — At least 6 in 10 adults in an older, more diverse U.S. to 61% of the U.S. population.
Pankaj Garg, MD mtaschetta-millane Fri, 07/12/2024 - 11:14 July 12, 2024 — Researchers have developed a groundbreaking method for analyzing heart MRI scans with the help of artificial intelligence , which could save valuable NHS time and resources, as well as improve care for patients.
Getty Images milla1cf Mon, 01/29/2024 - 14:24 January 29, 2024 — Despite national guidelines recommending surgical aortic valve replacement (SAVR) for patients under age 65 with severe aortic stenosis , many hospitals are still opting for a nonsurgical approach in patients under 60—possibly with poorer survival rates.
More than heartdisease or cancer, dementia is the primary concern for many of the patients I see. Heartdisease and cancer attack your body, but dementia attacks your mind and identity. We always need to examine how the outcome we are interested in changes. 2024 Jul 30:S0140-6736(24)01296-0. 2023 Mar 22.
Stroke: Vascular and Interventional Neurology, Volume 4, Issue 6 , November 1, 2024. Preexisting heartdisease spectrum was defined based on the combination pattern of coronary heartdisease, atrial fibrillation, and heart failure. versus 78.6%; aOR, 0.84 [95% CI, 0.750.95]).
mtaschetta-millane Thu, 07/11/2024 - 10:53 July 11, 2024 — Heart Test Laboratories, Inc. With the development of AI-ECG algorithms, HeartSciences improves the early identification of patients that need additional testing, allowing earlier treatment and improved patient outcomes.
Advancements in medical technology have revolutionized the diagnosis and treatment of heartdiseases, which pose critical chronic conditions that, if left unattended, can have fatal consequences. This improves diagnostic accuracy and ultimately leads to better patient outcomes.
milla1cf Thu, 04/04/2024 - 12:16 April 4, 2024 — Viz.ai , a leader in AI-powered disease detection and intelligent care coordination, announced new clinical data supporting advancements in cardiology care. The Viz HCM module is the first and only AI algorithm cleared by the FDA for HCM. “At
Getty Images milla1cf Tue, 03/19/2024 - 19:09 March 19, 2024 — The American College of Cardiology ( ACC ) has selected 50 learners for its 2024 – 2025 Clinical Trials Research (CTR) program , of whom 28 structural heart cardiologists and surgeons will participate in the CTR’s new Project REACH.
Circulation, Volume 150, Issue Suppl_1 , Page A4147397-A4147397, November 12, 2024. Background:Ischemic heartdisease (IHD) is a prevalent cardiovascular disease (CVD) associated with high morbidity and mortality. Frailty and CVD are often interrelated, affecting disease and treatment outcomes.
Image courtesy of El Camino Health milla1cf Thu, 06/13/2024 - 20:33 June 13, 2024 — Frederick St. Goar, MD, medical director at the Norma Melchor Heart & Vascular Institute , was distinguished with the Andreas Grüntzig Ethica Award , the highest global honor in interventional cardiology.
milla1cf Tue, 04/30/2024 - 13:03 April 30, 2024 — The expanding use of transcatheter technologies has changed the landscape in the treatment of valvular disease in adult cardiac patients, with valve surgery rapidly shifting to more complex interventions frequently involving other concomitant procedures. and 4.1%, respectively.
Circulation, Volume 150, Issue Suppl_1 , Page A4146823-A4146823, November 12, 2024. Variations in cardiogenic shock, MCS usage, and cardiac transplants emphasize the need for adaptive clinical practices to optimize patient outcomes.
Henry Ford Health's Center for Structural HeartDisease team delivered its first in Michigan FDA-approved VOQUE Transcatheter Tricuspid Valve Replacement System to a heart failure patient on February 13, 2024 at Henry Ford Hospital in Detroit. Medical Director of Structural HeartDisease at Henry Ford Health. “We
tim.hodson Tue, 09/17/2024 - 12:34 Sept. To access the entire AHA/ACC Scientific Statement please visit Key Data Elements and Definitions of Social Determinants of Health in Cardiology (Aug. If you enjoy this content, please share it with a colleague
Getty Images mtaschetta-millane Tue, 07/09/2024 - 07:23 July 9, 2024 — Disparities in cardiovascular diseaseoutcomes between urban and rural areas continue to widen, yet nearly half of U.S. The ACC aims to achieve a culture of equitable cardiovascular care and heart health for all.
Video Latin Heart Rounds: Tetralogy of Fallot Update kchalko Tue, 09/24/2024 - 16:04 This video is based on the Latin Heart Rounds webinar series on the current management of patients with tetralogy of Fallot, including neonates and on the current short and long term outcomes for this congenital heartdisease.
Photo: Edwards Lifesciences milla1cf Fri, 02/02/2024 - 09:33 February 2, 2024 — Edwards Lifesciences Corporation announced the company’s EVOQUE tricuspid valve replacement system is the first transcatheter therapy to receive U.S. Edwards expects to present the full cohort of 392 TRISCEND II pivotal trial patients at TCT 2024.
Questions to Ask We also urge parents to ask questions about what an individual center’s data means specifically for their diagnosis, like those found in our guide Questions to Ask Your Doctor About Congenital HeartDisease (CHD). This virtual summit is being held free of charge August 12, 2024. The post U.S.
Stroke, Volume 55, Issue Suppl_1 , Page ATP231-ATP231, February 1, 2024. We investigated the incidence of stroke and transient ischemic attack (TIA) in adults with congenital heartdisease (ACHD).Methods:A We investigated the incidence of stroke and transient ischemic attack (TIA) in adults with congenital heartdisease (ACHD).Methods:A
tim.hodson Tue, 08/27/2024 - 09:22 Aug. 22, 2024 – AISAP has announced that the U.S. We know that structural heartdisease and heart failure are the leading causes of hospitalization and morbidity in the U.S. The platform also offers telemedicine, cloud computing and education tools.
Circulation, Volume 150, Issue Suppl_1 , Page A4120458-A4120458, November 12, 2024. Introduction:School engagement, or caring about doing well and doing required homework, is an important factor for academic success and may contribute to poorer academic outcomes in children born with heartdisease (HD), compared to heart-healthy peers.
milla1cf Wed, 01/31/2024 - 17:10 January 31, 2024 — Royal Philips , a global leader in health technology, announced that its latest TEE transducer, designed to serve more patients with improved overall comfort, has received FDA 510(k) clearance. In structural heartdisease, the quality of a 3D TEE image can help save lives.
milla1cf Thu, 04/25/2024 - 17:21 April 25, 2024 — Atlantic Health System ’s Morristown Medical Center treated the first patient in New Jersey using Edwards Lifesciences EVOQUE tricuspid valve replacement, the first transcatheter therapy to receive U.S.
milla1cf Wed, 02/28/2024 - 19:59 February 28, 2024 — Royal Philips , a global leader in health technology, announced major enhancements to its Image Guided Therapy System – Azurion – with the launch of its new Azurion neuro biplane system. The faster stroke is treated, the better the potential outcome. Lancet Public Health.
Caristo Diagnostics Limited has announced the results of a landmark clinical study published in The Lancet that support the ability of Caristo's CaRi-Heart AI technology to quantify coronary artery inflammation and accurately predict cardiac events. Details of the study, included in a written statement issued by Caristo Diagnostics, follow.
Story Health has a proven track record of engaging patients with heart conditions in their health and improving outcomes,” said Guidehealth Co-founder and CEO Sanjay Doddamani, MD, who also is a cardiologist. Reducing total costs doesn’t have to come at the expense of delivering high-quality care at scale.
Demographic, clinical, radiographic, treatment and outcome data were collected via chart review and entered into a secure, HIPAA-compliant RedCAP database. Overall, MCS patients were younger and were more likely to have congenital or acquired heartdisease than non-MCS patients.
tim.hodson Mon, 10/21/2024 - 15:52 Earlier this year, Materialise, a global supplier of 3D printing software and services, acquired FEops , a Belgian company that develops AI-driven simulation technology to improve procedure efficiency and clinical outcomes for structural heart interventions.
Image courtesy: ACC christine.book Thu, 02/29/2024 - 11:22 February 29, 2024 — The American College of Cardiology ( ACC ) will soon be holding its ACC 73rd Annual Scientific Session & Expo , ACC.24 24 from April 6 - 8, 2024 in Atlanta, GA at the Georgia World Congress Center.
milla1cf Mon, 03/18/2024 - 07:30 March 18, 2024 — SS Innovations International, Inc. , milla1cf Mon, 03/18/2024 - 07:30 March 18, 2024 — SS Innovations International, Inc. , To date, more than 800 surgical procedures have been conducted using the system.
The NLA Scientific Sessions (May 30-June 2, 2024) has concluded, providing key insights into lipid management and cardiovascular health. Inflammation Takes Center Stage in HeartDisease : Dr. Michael S. Garshick unveiled the pivotal role of inflammation in heartdisease treatment. Learn more here !
Physicians in the Smidt Heart Institute at Cedars-Sinai have pioneered using a catheter-based approach to treat patients with tricuspid valve disease. If a valve cannot open or close fully it can interfere with blood flow and cause a host of health issues, including heart attack and stroke. Image by Getty. million people.
Data collection included demographic characteristics, clinical outcomes, hospitalization details, and surgical treatment. Surgical intervention remains the mainstay of treatment, with favorable outcomes when performed promptly. Ethical approval was obtained, and descriptive statistics were employed for data analysis using SAS 9.4.ResultsAt
milla1cf Sun, 04/07/2024 - 18:20 April 7, 2024 — An estimated 1 in 5 U.S. adults—and more than 2 in 5 adults aged 60 years and older—have elevated triglycerides, also known as hypertriglyceridemia , putting them at an increased risk for heart attacks and stroke. Patients were followed for one year of treatment.
Image courtesy: Getty Images christine.book Thu, 02/08/2024 - 16:57 February 8, 2024 — The American Heart Association ( AHA ), currently celebrating its centennial year, announced that it is providing $450,000 in grants to assess its new risk prediction tool among diverse race, age, geographic and socioeconomic groups.
Journal of the American Heart Association, Volume 13, Issue 2 , January 16, 2024. BackgroundAmerican Indians face significant barriers to diagnosis and management of cardiovascular disease.
milla1cf Wed, 01/03/2024 - 11:45 January 3, 2024 — HeartFlow, Inc. , With more than 500 peer-reviewed publications, the HeartFlow FFR CT Analysis remains unparalleled in precision coronary care, as supported by the ACC/AHA Chest Pain Guidelines, to improve treatment plans and outcomes. Arbab-Zadeh, Heart Int 2012.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content